In this article, James Matera, DO, writes about the benefits of using SGLT2 inhibitors to treat patients with type 2 diabetes, chronic kidney disease, and cardiovascular disease, including how the use of...
In this commentary, Charlotte Owens, MD, reviews data from the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, including study findings on treatment options for...
In this Editorial, Editorial Board Member Michael J. Bloch, MD, reflects on a 1985 article from Consultant’s archives about how to properly use the laboratory to monitor drug therapy among patients with...
